Specificity was lowest in IDH-wt GBM (68.3% ± 9.1%) compared to IDH-mut astrocytoma (85.2% ± 4.6%) and IDH-mut 1p/19q codeleted ODG (86.0% ± 10.4%). This evidence concerns the gene IDH1 and glioblastoma.